Orthofix Medical (OFIX) Profit After Tax Growth (1y) (2011 - 2026)
Orthofix Medical (OFIX) Profit After Tax Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 16.04% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 99.26% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 4.70% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 89.28% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -27.13% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 108.33% |
| 10 | Orthofix Medical | 480.55 Mn | 359.68 Mn | 139.55 Mn | -1,324.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,324.74% |
| Dec 31, 2025 | 92.38% |
| Sep 30, 2025 | 9.74% |
| Jun 30, 2025 | 57.90% |
| Mar 31, 2025 | 175.83% |
| Dec 31, 2024 | 80.69% |
| Sep 30, 2024 | -1,358.85% |
| Jun 30, 2024 | -4,090.81% |
| Mar 31, 2024 | 101.04% |
| Dec 31, 2023 | -4,086.03% |
| Sep 30, 2023 | 86.58% |
| Jun 30, 2023 | -66.33% |
| Mar 31, 2023 | -5,144.23% |
| Dec 31, 2022 | 399.53% |
| Sep 30, 2022 | -501.43% |
| Jun 30, 2022 | 2.85% |
| Mar 31, 2022 | 26.13% |
| Dec 31, 2021 | -369.51% |
| Sep 30, 2021 | -195.43% |
| Jun 30, 2021 | 63.07% |